UCSC Human Gene Sorter
 
genome assembly search
sort by display output
#
Name
VisiGene
BLASTP
E-Value
Genome Position
Description                                       
1ISL2n/a
n/a
n/a
n/a
0chr15 76,339,624ISL LIM homeobox 2 (from RefSeq NM_145805.3)
2ENSG00000259514n/a
    
    
     
n/achr15 76,340,836ENSG00000259514 (from geneSymbol)
3CPA6n/a
n/a
n/a
n/a
n/achr8 67,584,199carboxypeptidase A6 (from RefSeq NM_020361.5)
4SNORD88Bn/a
n/a
n/a
n/a
n/achr19 50,799,077small nucleolar RNA, C/D box 88B (from RefSeq NR_003068.1)
5FOXF2-DTn/a
    
    
     
n/achr6 1,384,428FOXF2-DT (from geneSymbol)
6ENSG00000224090n/a
    
    
     
n/achr2 219,008,968uncharacterized LOC100129175 (from RefSeq NR_046086.1)
7RLN2n/a
n/a
n/a
n/a
n/achr9 5,302,290relaxin 2, transcript variant 1 (from RefSeq NM_134441.3)
8LINC00954n/a
n/a
n/a
n/a
n/achr2 19,876,960long intergenic non-protein coding RNA 954 (from RefSeq NR_033875.1)
9ASS1P1n/a
    
    
     
n/achr6 25,023,865argininosuccinate synthetase 1 pseudogene 1 (from HGNC ASS1P1)
10KMT5AP3n/a
    
    
     
n/achr3 170,062,597KMT5AP3 (from geneSymbol)
11LINC00578n/a
n/a
n/a
n/a
n/achr3 177,604,653long intergenic non-protein coding RNA 578 (from HGNC LINC00578)
12ENSG00000272264n/a
    
    
     
n/achr8 80,033,012ENSG00000272264 (from geneSymbol)
13ENSG00000261266n/a
n/a
n/a
n/a
n/achr16 23,687,369ENSG00000261266 (from geneSymbol)
14MIR429n/a
    
    
     
n/achr1 1,169,046microRNA 429 (from RefSeq NR_029957.1)
15GJB7n/a
n/a
n/a
n/a
n/achr6 87,306,129gap junction protein beta 7 (from RefSeq NM_198568.3)
16HCG4P8n/a
    
    
     
n/achr6 29,827,874HLA complex group 4 pseudogene 8 (from HGNC HCG4P8)
17STON1-GTF2A1Ln/a
n/a
n/a
n/a
n/achr2 48,604,764Cytoplasm  Nucleus (from UniProt Q53S48)
18ARID3BP1n/a
    
    
     
n/achr1 81,502,631ARID3BP1 (from geneSymbol)
19ENSG00000262714n/a
    
    
     
n/achr16 53,388,014ENSG00000262714 (from geneSymbol)
20VOPP1-DTn/a
    
    
     
n/achr7 55,580,753VOPP1-DT (from geneSymbol)
21RPL12P25n/a
    
    
     
n/achr9 478,102ribosomal protein L12 pseudogene 25 (from HGNC RPL12P25)
22ENSG00000293144n/a
    
    
     
n/achr9 478,086ENSG00000293144 (from geneSymbol)
23MYB-AS1n/a
    
    
     
n/achr6 135,195,539MYB antisense RNA 1 (from HGNC MYB-AS1)
24RLN1n/a
n/a
n/a
n/a
n/achr9 5,337,403relaxin 1 (from RefSeq NM_006911.4)
25HOXB-AS2n/a
    
    
     
n/achr17 48,558,797HOXB cluster antisense RNA 2 (from HGNC HOXB-AS2)
26ENSG00000258837n/a
    
    
     
n/achr14 68,127,600ENSG00000258837 (from geneSymbol)
27ENSG00000233977n/a
    
    
     
n/achr7 55,592,633ENSG00000233977 (from geneSymbol)
28PTMAP3n/a
    
    
     
n/achr20 18,012,119prothymosin alpha pseudogene 3 (from HGNC PTMAP3)
29PDE6An/a
n/a
n/a
n/a
n/achr5 149,901,373phosphodiesterase 6A, transcript variant 1 (from RefSeq NM_000440.3)
30ENSG00000227598n/a
    
    
     
n/achr6 166,984,345ENSG00000227598 (from geneSymbol)
31RAD1P2n/a
    
    
     
n/achr1 159,081,464RAD1 pseudogene 2 (from HGNC RAD1P2)
32ANAPC1P1n/a
n/a
n/a
n/a
n/achr2 86,892,139ANAPC1 pseudogene 1 (from RefSeq NR_037931.2)
33IGHV1-3n/a
n/a
n/a
n/a
n/achr14 106,005,334V region of the variable domain of immunoglobulin heavy  chains that participates in the antigen recognition (PubMed:24600447).  Immunoglobulins, also known as antibodies, are membrane-bound or  secreted glycoproteins produced by B lymphocytes. In the recognition  phase of humoral immunity, the membrane-bound immunoglobulins serve as  receptors which, upon binding of a specific antigen, trigger the clonal  expansion and differentiation of B lymphocytes into immunoglobulins-  secreting plasma cells. Secreted immunoglobulins mediate the effector  phase of humoral immunity, which results in the elimination of bound  antigens (PubMed:22158414, PubMed:20176268). The antigen binding site  is formed by the variable domain of one heavy chain, together with that  of its associated light chain. Thus, each immunoglobulin has two  antigen binding sites with remarkable affinity for a particular  antigen. The variable domains are assembled by a process called V-(D)-J  rearrangement and can then be subjected to somatic hypermutations  which, after exposure to antigen and selection, allow affinity  maturation for a particular antigen (PubMed:20176268, PubMed:17576170). (from UniProt A0A0C4DH29)
34ZNF695n/a
n/a
n/a
n/a
n/achr1 246,996,690zinc finger protein 695, transcript variant 1 (from RefSeq NM_020394.5)
35ENSG00000256064n/a
    
    
     
n/achr12 130,420,277ENSG00000256064 (from geneSymbol)
36SCARNA22n/a
    
    
     
n/achr4 1,974,698small Cajal body-specific RNA 22 (from RefSeq NR_003004.1)
37ENSG00000268777n/a
    
    
     
n/achr19 51,519,995ENSG00000268777 (from geneSymbol)
38SCARNA21n/a
    
    
     
n/achr17 7,906,191small Cajal body-specific RNA 21 (from RefSeq NR_003000.1)
39GPR25n/a
n/a
n/a
n/a
n/achr1 200,873,579G protein-coupled receptor 25 (from RefSeq NM_005298.4)
40ENSG00000261583n/a
    
    
     
n/achr16 23,712,391ENSG00000261583 (from geneSymbol)
41ENSG00000232306n/a
n/a
n/a
n/a
n/achr2 238,298,006ENSG00000232306 (from geneSymbol)
42ARL4AP2n/a
    
    
     
n/achr4 40,786,410ADP ribosylation factor like GTPase 4A pseudogene 2 (from HGNC ARL4AP2)
43TLX2n/a
n/a
n/a
n/a
n/achr2 74,515,799T cell leukemia homeobox 2 (from RefSeq NM_016170.5)
44RPL12P1n/a
    
    
     
n/achr6 33,400,307ribosomal protein L12 pseudogene 1 (from HGNC RPL12P1)
45ENSG00000250893n/a
    
    
     
n/achr4 40,426,852ENSG00000250893 (from geneSymbol)
46GHSRn/a
    
    
     
n/achr3 172,445,873growth hormone secretagogue receptor, transcript variant 1a (from RefSeq NM_198407.2)
47ENSG00000254094n/a
    
    
     
n/achr4 1,357,328ENSG00000254094 (from geneSymbol)
48QRFPn/a
n/a
n/a
n/a
n/achr9 130,894,759pyroglutamylated RFamide peptide (from RefSeq NM_198180.3)
49ENSG00000250081n/a
    
    
     
n/achr5 65,486,746ENSG00000250081 (from geneSymbol)
50ENSG00000267349n/a
    
    
     
n/achr17 35,478,219ENSG00000267349 (from geneSymbol)